Lundbeck
HLUN-B.CO
#2294
Rank
NZ$14.43 B
Marketcap
NZ$14.55
Share price
0.18%
Change (1 day)
13.89%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): NZ$1.31

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.35. In 2025 the company made an earnings per share (EPS) of NZ$0.90 an increase over its 2024 EPS that were of NZ$0.79.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.3145.58%
2025NZ$0.9014.5%
2024NZ$0.7929.29%
2023NZ$0.6123.09%
2022NZ$0.4937.26%
2021NZ$0.36-84.61%
2020NZ$2.34-24.61%
2019NZ$3.10-42.06%
2018NZ$5.3540.7%
2017NZ$3.80146.26%
2016NZ$1.54-120.48%
2015NZ-$7.533231.32%
2014NZ-$0.23-115.78%
2013NZ$1.43-23.36%
2012NZ$1.87-48.01%
2011NZ$3.60-9.68%
2010NZ$3.9813.72%
2009NZ$3.5024.32%
2008NZ$2.82-6.05%
2007NZ$3.0081.77%
2006NZ$1.65-16.76%
2005NZ$1.98-17.58%
2004NZ$2.40